When TGFBR1 was inhibited, the inhibitory effect of BBR on trans-endothelial migration of AsPC-1 cells was blunted (Figure 4A), indicating that BBR prevented the trans-endothelial migration of cancer cells by interrupting TGF-β1 signaling. Here, TGFB1 is linked to cancer.